Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2020 | Prostate cancer: PSMA-PET

Jeremie Calais • 13 Feb 2020
GU Cancers 2020
Genitourinary Cancer Prostate Cancer

Jeremie Calais, MD, University of California, Los Angeles, CA, discusses the integration of PSMA-PET imaging in the prostate cancer space. This interview was recorded at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

More from Jeremie Calais

2:10
Exploring the new frontier: radionuclide therapy in metastatic prostate cancer
Jeremie Calais • 3 Jun 2023
4:16
PSMA PET guided salvage RT among patients with prostate cancer in the post-prostatectomy setting
Jeremie Calais • 3 Jun 2023
2:10
Integrating radioligand therapy for prostate cancer in US clinical practice
Jeremie Calais • 4 Jun 2023
2:56
PSMA PET ratio predicts response to [177Lu]PSMA radioligand therapy: a multicenter study
Jeremie Calais • 4 Jun 2023

Related Videos

4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
0:45
SYNC-T combination immunotherapy in mCRPC
George Prendergast • 8 Apr 2024
0:40
PSMA PET findings in 225AC-J591-treated patients with mCRPC
Andres Ricaurte-Fajardo • 9 Apr 2024
0:45
Should radioligand therapies be used in earlier settings in prostate cancer?
Andres Ricaurte-Fajardo • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals